Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) as Compared With Methylphenidate in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Multicentre Randomized Clinical Study

NCT02778360 is registered in ClinicalTrials.gov with Mensia Technologies SA as lead sponsor.

NCT NCT02778360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02778360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) as Compared With Methylphenidate in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Multicentre Randomized Clinical Study
Lead sponsor
Mensia Technologies SA
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2016
Completion date
September 30, 2017
Enrollment
179 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit-hyperactivity disorder